The exact underlying mechanisms associated with CHB in utero have been linked to anti-SS-A/Ro and anti-SS-B/La antibodies, and result in neonatal transient skin rash, liver abnormalities, and thrombocytopenia. This evidence concerns the gene TRIM21 and Thrombocytopenia.